Canada Biotechnology & Medical Research

NervGen Pharma Corp (NGEN)

Track

Track

NervGen Pharma Corp recently recorded a single purchase transaction by director John Ruffolo. This activity follows a period marked by significant buying from other board members and major shareholders earlier this year, contrasting with earlier divestments by Krista McKerracher. These movements occurred after the April 2026 results financiers report.
Ticker: NGEN Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NervGen Pharma Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ruffolo, John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
146.99
Quantity 86,552
Value US$2,288,584
Ruffolo, John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
447.42
Quantity 40,487
Value CA$3,482,214
Ruffolo, John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
329.57
Quantity 67,158 -28.2%
Value US$2,437,589
Rogers, Adam Director of Issuer, Director or Senior Officer of 10% Security Holder Non-Executive Director
Transaction date
Purchase
Price
2.50
Quantity 800,000 +8.0%
Value US$2,000,000
2.3
Punnett, Harold 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.74
Quantity 4,250 +0.4%
Value US$15,912
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.19
Quantity 10,000 -26.5%
Value US$41,914
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.23
Quantity 5,000 -11.7%
Value US$21,150
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
3.98
Quantity 5,000 -10.5%
Value US$19,924
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
3.85
Quantity 10,000 -17.3%
Value US$38,517
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.10
Quantity 5,000 -8.0%
Value US$20,514
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.13
Quantity 5,000 -7.4%
Value US$20,639
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.30
Quantity 9,980 -12.8%
Value US$42,914
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.30
Quantity 20 -0.0%
Value US$86
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.18
Quantity 10,000 -11.4%
Value US$41,773
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.13
Quantity 10,000 -10.2%
Value CA$41,312
3.1
McKerracher, Krista Director of Issuer Non-Executive Director
Transaction date
Sale
Price
4.00
Quantity 10,000 -9.3%
Value US$39,958
3.1
Bayley, Brian Eric Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.10
Quantity 250,000 +79.4%
Value US$525,000
Rogers, Adam Director of Issuer, Director or Senior Officer of 10% Security Holder Non-Executive Director
Transaction date
Purchase
Price
2.10
Quantity 857,143
Value US$1,800,000
Rogers, Adam Director of Issuer, Director or Senior Officer of 10% Security Holder Non-Executive Director
Transaction date
Purchase
Price
2.10
Quantity 952,381 +33.1%
Value US$2,000,000
2.8
Radvak, William Joseph Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 20,000 +1.4%
Value CA$47,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-07-28 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
86,552
146.99
US$2,288,584 		86,552 146.99 US$2,288,584
2026-06-01 2026-05-27 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
40,487
447.42
CA$3,482,214 		40,487 447.42 CA$3,482,214
2026-06-01 2026-05-27 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
67,158 -28.2%
329.57
US$2,437,589 		67,158 -28.2% 329.57 US$2,437,589
2026-06-03 2026-05-26 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
800,000 +8.0%
2.50
US$2,000,000 		800,000 +8.0% 2.50 US$2,000,000
2026-05-04 2026-04-29 B Purchase
2.3
Punnett, Harold

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
4,250 +0.4%
3.74
US$15,912 		4,250 +0.4% 3.74 US$15,912
2026-04-08 2026-04-08 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -26.5%
4.19
US$41,914 		10,000 -26.5% 4.19 US$41,914
2026-04-08 2026-04-02 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -11.7%
4.23
US$21,150 		5,000 -11.7% 4.23 US$21,150
2026-03-13 2026-03-09 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -10.5%
3.98
US$19,924 		5,000 -10.5% 3.98 US$19,924
2026-03-02 2026-03-02 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -17.3%
3.85
US$38,517 		10,000 -17.3% 3.85 US$38,517
2026-03-02 2026-02-26 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -8.0%
4.10
US$20,514 		5,000 -8.0% 4.10 US$20,514
2026-03-02 2026-02-26 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -7.4%
4.13
US$20,639 		5,000 -7.4% 4.13 US$20,639
2026-02-23 2026-02-20 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
9,980 -12.8%
4.30
US$42,914 		9,980 -12.8% 4.30 US$42,914
2026-02-23 2026-02-19 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
20 -0.0%
4.30
US$86 		20 -0.0% 4.30 US$86
2026-02-23 2026-02-19 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -11.4%
4.18
US$41,773 		10,000 -11.4% 4.18 US$41,773
2026-02-23 2026-02-18 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -10.2%
4.13
CA$41,312 		10,000 -10.2% 4.13 CA$41,312
2026-02-16 2026-02-12 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -9.3%
4.00
US$39,958 		10,000 -9.3% 4.00 US$39,958
2025-11-20 2025-11-19 B Purchase
3.1
Bayley, Brian Eric

Director of Issuer

Non-Executive Director
250,000 +79.4%
2.10
US$525,000 		250,000 +79.4% 2.10 US$525,000
2025-11-19 2025-11-19 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
857,143
2.10
US$1,800,000 		857,143 2.10 US$1,800,000
2025-11-19 2025-11-19 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
952,381 +33.1%
2.10
US$2,000,000 		952,381 +33.1% 2.10 US$2,000,000
2024-03-29 2024-03-28 B Purchase
2.8
Radvak, William Joseph

Director of Issuer

Non-Executive Director
20,000 +1.4%
2.35
CA$47,000 		20,000 +1.4% 2.35 CA$47,000
Explore more

More insider trading research around NervGen Pharma Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America